Dismissing manufactured uncertainties, limitations and competing interpretations about chemical exposures and diabetes

Journal of Epidemiology and Community Health

Volumn 71, Issue 9, 2017, Pages 942-

  Trasande, Leonardo ^a,b,c   Lind, P Monica ^d   Lampa, Erik ^e   Lind, Lars ^d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d UPPSALA UNIVERSITY   (Sweden)

^e UPPSALA CLINICAL RESEARCH CENTER   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; HUMAN;

DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; HUMANS;

EID: 85027250464     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech-2017-208901     Document Type: Letter

References (16)

1. Ngwa EN, Kengne AP, Tiedeu-Atogho B, et al. Persistent organic pollutants as risk factors for type 2 diabetes. Diabetol Metab Syndr 2015;7:41.
2. Trasande L, Lampa E, Lind L, et al. Population attributable risks and costs of diabetogenic chemical exposures in the elderly. J Epidemiol Community Health 2017;71:111-4.
3. Lind L, Lind PM. Can persistent organic pollutants and plastic-associated chemicals cause cardiovascular disease? J Intern Med 2012;271:537-53.
4. Lind L, Zethelius B, Salihovic S, et al. Circulating levels of perfluoroalkyl substances and prevalent diabetes in the elderly. Diabetologia 2014;57:473-9.
5. Lind PM, Zethelius B, Lind L. Circulating levels of phthalate metabolites are associated with prevalent diabetes in the elderly. Diabetes Care 2012;35:1519-24.
6. Lee DH, Lind PM, Jacobs DR, Jr., et al. Polychlorinated biphenyls and organochlorine pesticides in plasma predict development of type 2 diabetes in the elderly: the prospective investigation of the vasculature in Uppsala Seniors (PIVUS) study. Diabetes Care 2011;34:1778-84.
7. Legler J, Fletcher T, Govarts E, et al. Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European union. J Clin Endocrinol Metab 2015;100:1278-88.
8. Attina TM, Hauser R, Sathyanarayana S, et al. Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis. Lancet Diabetes Endocrinol 2016;4:996-1003.
9. Trasande L, Zoeller RT, Hass U, et al. Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis. Andrology 2016;4:565-72.
10. Trasande L. Stand firm on hormone disruptors. Nature 2016;539:469.
11. Trasande L, Vandenberg LN, Bourguignon JP, et al. Peer-reviewed and unbiased research, rather than 'sound science', should be used to evaluate endocrine-disrupting chemicals. J Epidemiol Community Health 2016;70:1051-6.
12. Damstra T, Barlow S, Bergman A, et al. eds. Global assessment of the state-of-the-science of endocrine disruptors. Geneva, Switzerland: World Health Organization, 2002.
13. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, et al. Endocrine-disrupting chemicals: an endocrine society scientific statement. Endocr Rev 2009;30: 293-342.
14. Gore AC, Chappell VA, Fenton SE, et al. EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals. Endocr Rev 2015;36: E1-150.
15. Bergman Å, Heindel JJ, Jobling S, et al, eds. Global assessment of state-of-the-science for endocrine disruptors. 2012. http://www.who.int/ipcs/publications/new_issues/endocrine_disruptors/en/ (accessed 6 Oct 2014).
16. Di Renzo GC, Conry JA, Blake J, et al. International Federation of Gynecology and Obstetrics opinion on reproductive health impacts of exposure to toxic environmental chemicals. Int J Gynaecol Obstet 2015;131:219-25.